GET THE APP

Role of Plasma Cytokines and Endotoxin in Patients with Acute Aor
Immunome Research

Immunome Research
Open Access

ISSN: 1745-7580

+44-20-4587-4809

Review Article - (2016) Volume 12, Issue 2

Role of Plasma Cytokines and Endotoxin in Patients with Acute Aortic Dissection

Firoj KM*, Fa XE, Yu HB and Huang ZF
Department of Cardio-vascular Surgery, 2nd Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
*Corresponding Author: Firoj KM, Department of Cardio-vascular Surgery, 2nd Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, Tel: 008613027787275 Email:

Abstract

Objective: To analyze the role of plasma cytokines and endotoxin in patients with acute aortic dissection (AAD) in concluding prognostic effect. Material and methods: A total of 85 patients with acute aortic dissection were admitted in 2nd affiliated hospital of Zhengzhou university from January 2009 to November 2015. Patients were divided into death group and survival group. At the time of admission (T1), 12 hours after admission (T2), 24 hours after admission (T3), the plasma level of interleukin-6 (IL-6), interleukin- 10 (IL-10), tumor necrosing factor- alpha(TNF-α) and endotoxins were measured. Results: The plasma level of IL-6, TNF-α and endotoxins in death group at each time point were significantly higher than survival group (F group=3.194, 5.973, 9.156, P<0.05. There were significant difference of IL-6, TNF-α and endotoxins levels among three time points in two groups (F time=5.135, 11.548, 8.875, P<0.05. IL-6, TNF-α levels in the survival group at T3, IL-6 level in death group at T2, IL-6, TNF-α and endotoxins levels in the death group at T3 were significantly higher than T1, P<0.05. There was no significant difference in IL-10 level between two groups and among three time points (F group=1.674, F time=2.901, P>0.05. Conclusion: Plasma level of IL-6, TNF-α and endotoxin are increased in the acute aortic dissections showing the progressive development of AAD. Our findings in this study indicate the role of inflammation during AAD. The changing pattern of these markers can be used for diagnosis and prophylactic treatment of AAD.

<

Keywords: Acute, aortic, dissection (AAD), Cytokines, TNF-α, Endotoxin

Introduction

Acute dissection of the aorta is an uncommon yet potentially catastrophic clinical event that mandates prompt recognition and expeditious treatment. Diagnosis begins with a high clinical index of suspicion in a patient presenting with chest pain and one or more predisposing risk factors, most notably, hypertension or an inherited disorder of connective tissue.Aortic dissection is characterized by medial degeneration with intimal tear and crossing of blood into the artery wall, leading to the formation of a false lumen and subsequent systemic inflammatory responses [1]. Interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-α (TNF-α) are major proinflammatory cytokines, and their increasing levels have been demonstrated to be closely related to the progression of dissection and TAAD-related complications [2,3].

In clinical practice, TEE or contrast-enhanced CT scanning has become the initially preferred diagnostic strategy for the assessment of patients with suspected acute aortic syndromes. The use of MRI has been limited by the restricted availability of the magnets and by considerations of patient safety while undergoing study.

Our aim of this study is to find out the relationship between the rising of major pro-inflammatory cytokines with the progression of AAD.

Material and Methods

From January 2009 to November 2015, after excluding the patients who died before emergency surgical intervention, 85 cases of acute aortic dissection were admitted and performed successful emergency surgery, including 51 males and 34 females. Aged 35-67 years, duration from onset of disease to the emergency surgery was 18-43 hours. After the surgery, patients were divided into two groups according to the prognosis, survival group (69 cases) and death group (16 cases). In two groups, duration from onset of disease to the emergency surgery, gender, age, systolic and diastolic blood pressure at the time of admission were compared, the differences were not statistically significant as shown in the Table 1 below.

Venous blood of the patients were drawn and the plasma was separated to use for ELISA test through which the plasma level of IL-6, IL-10 and TNF-α were measured out at time, T1=at the time of admission, T2=12 hours after the admission, T3=24 hours after the admission.

Group N(M/F) T(/h) Age/year SBD/mmHg DBP/mmHg
Survival 69(41/28) 11.5 ± 7.4 48 ± 14 146 ± 23 96 ± 14
Death 16(10/6) 10.9 ± 8.7 45 ± 13 139 ± 21 97 ± 10
X2/t   0.051 0.283 0.782 1.114 0.270
P 0.821 0.778 0.436 0.269 0.788

Table 1: General comparison of survival and death groups.

Main steps of measurement: in the holes of standard and sample microplate, biotin marker fluid was added, wash gently in microplate washer after incubating the reaction, then an enzyme labeled marker liquid is added and incubate the reaction in dark at 37, wash again after the reaction in the same way above in the micro plate washer. Termination buffer is added to stop the reaction. Micro-plates are kept on the ELISA reader or micro-plate reader at 450 nm to read the light absorbance and find out the corresponding level of the sample in the standard curve.

Plasma endotoxin levels in both groups were measured by using LIMULUS kit, (endotoxin assay kit). Important steps: draw anticoagulated plasma, water bath, oscillation or shaking, collect the supernatant, adding buffer solution, then add the limulus reagent, after water bath add successively, sodium nitrate, sulfur amino amines, naphthylethylenediamine, and put on the spectrophotometer to see the corresponding color absorbance at spectral light of 721 degree. According to the absorbance value in the standard curve, the plasma levels of endotoxin were checked.

Statistical analysis

SPSS 11.5 was used to analyze the data, plasma level of cytokines and endotoxins in two groups were compared using variance analysis of repeated measured data, test level α=0.05

Result

Comparisons of plasma cytokines and endotoxins in two groups at different time are shown in the Table 2. From the Table 2, compared with the survival group, the plasma levels of IL-6, TNF-α and endotoxins were increased at each time of measurement in the death group. Within the survival and death group, the comparisons of plasma IL-6, TNF-α and endotoxin at each time point were statistically significant. In the survival group, plasma level of IL-6, TNF-α at T3 is higher than in T1, in the death group, plasma level of IL-6 at T2, plasma level of IL-6, TNF-α and endotoxin at T3 are raised. While comparing the Plasma level of IL-10 in each time of measurement in the two groups, the differences were not statistically significant.

Group n IL-6        TNF-α Endotoxin IL-10
Survival
T1 69 0.04 ± 0.02 23.32 ± 12.67 31.55 ± 5.78 30.13 ± 19.97
T2 69 0.07 ± 0.13 33.35 ± 17.32 31.74 ± 6.98 33.77 ± 19.21
T3 69 0.15 ± 0.07 46.56 ± 54.42 32.26 ± 4.18 33.38 ± 32.74
Death
T1 16 0.08 ± 0.02 33.47 ± 13.14 41.13 ± 19.97 31.55 ± 5.78
T2 16 0.18 ± 0.04 53.77 ± 19.21 53.77 ± 19.21 31.74 ± 6.98
T3 16 0.24 ± 0.05 101.38 ± 32.74 101.38 ±32.74 32.26 ± 4.18
Fgroup   3.914(0.041) 5.973(0.023) 9.15(0.014) 1.674(0.195)
Ftime   5.135(0.036) 11.548(0.005) 8.875(0.015) 2.901(0.089)

Table 2:Comparing plasma level of IL-6, TNF-α, endotoxins and IL-10 in survival and death group mg/L.

Discussion

The Stanford type A Aortic Dissection (TAAD) is associated with severe morbidity and mortality. [1,2]. Patients without optimal medical treatment have a mortality rate of 50-68% during the first 48 hours after an acute event, with a mean mortality of up to 1% per hour, and reaches as high as 90% within 3 months [3]. Despite the continuous advances of diagnostic technologies during recent years [4], it remains difficult to assess the progression of TAAD accurately.

Hospital and long-term survival has improved substantially over the past 40 years, yet there remains ample room for continued progress. For centers with an active interest in the evaluation and management of acute dissection, hospital mortality rates have been lowered to 15% to 25% [5-7]. Five-year actuarial survival rates range between 50% and 70%,[6-9] with a 7% to 20% incidence of late reoperation, usually for aneurysmal enlargement or re-dissection [6,10,11]

Acute aortic dissection is a dreaded, life threatening, rapidly progressing cardiovascular disease with high mortality rates. Aortic dissection may lead to systemic inflammatory response syndrome (SIRS) and even may cause multiple organ dysfunction syndromes (MODS) [12-15]. Aortic dissection leads to the formation of true and false lumen of the aorta, the blood flow in the false lumen causes further development of downstream false lumen. With the progression of dissection, blood volume in the false lumen increases which causes compression of true lumen reducing blood supply to the distal organs including intestines leading to systemic tissue ischemia [16,17]. In addition to the blood occupying false lumen leading to tissue ischemia, plasma cytokines and endotoxin released after the stress in acute aortic dissection can also lead to SIRS. According to authors, whether in survival or death group, after the acute aortic dissection, the plasma endotoxin and pro-inflammatory factors like IL-6, TNF-α are sharply increased; explaining that outbreak of cytokines and endotoxin after the event of acute aortic dissection can lead to SIRS.

Previous studies reported that injury or severe illness, even dirty operation can result in an increase in plasma cytokines and endotoxin [18]. Changes in plasma level of cytokines and endotoxins can also reflect the severity of the patient’s condition [19]. Continuous determination of plasma endotoxins and inflammatory mediators can help to predict the prognosis of patients and improve the physician’s emphasis on such patients to provide early intervention and treatment [20]. Suitable inflammatory mediators in patients with acute aortic dissection can not only reflect severity of systemic inflammatory response but also can predict the prognosis of patients by monitoring the variations in plasma level of inflammatory mediators with time. In recent years, many articles have reported the variation of SIRS in patients with acute aortic dissection.

Wen et al. analyzed the relationship between the prognosis and plasma level of inflammatory mediators [2]. Nomura et al. compared the plasma levels of inflammatory mediators in patients with and without the residual dissection [21]. The above studies confirmed that plasma level of cytokines have a strong association with acute aortic dissection. Current evidence demonstrated a significant infiltration of macrophages and neutrophils in the dissected aortic wall [22]. These recruited leukocytes could release a series of pro-inflammatory cytokines, which would further accelerate the progression of dissection and lead to systemic complications. Early detection of proinflammatory mediators and increase anti-inflmmatory response can improve the survival rate of the patients [1-3]. A sharp increase of plasma IL-6, TNF-α and endotoxins in patients with AAD may indicate a poor prognosis.

Conclusion

In this small sample size, prospective study, we demonstrated that the plasma level of pro-inflammatory cytokines, IL-6, TNF-α and endotoxins in death group at each time point were higher than the survival group but level of anti-inflammatory cytokines, IL-10 between the two groups did not show any significant difference. It explains clearly that after the onset of AAD, pro-inflammatory mediators are dramatically increased and anti-inflammatory mediators are unable to rise to weaken the SIRS which may be the cause of poor prognosis. So clinicians should try to improve the importance and the best way of treating these diseases as soon as possible.

References

  1. Parolari A, Tremoli E, Songia P, Pilozzi A, Di Bartolomeo R, et al. (2013) Biological features of thoracic aortic diseases. where are we now, where are we heading to: established and emerging biomarkers and molecular pathways. Eur J CardiothoracSurg 44: 9-23.
  2. Wen D, Zhou XL, Li JJ, Luo F, Zhang L, et al. (2012) Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-alpha and matrix metalloproteinase-9 in aortic dissection. ClinChimActa 413:198-202.
  3. Okina N, Ohuchida M, Takeuchi T, Fujiyama T, Satoh A, et al. (2013) Utility of measuring C-reactive protein for prediction of in-hospital events in patients with acute aortic dissection. Heart Vessels 28:330-335.
  4. Sheikh AS, Ali K, Mazhar S  (2013) Acute aortic syndrome. Circulation 128:1122-1127.
  5. Qian H, Hu J, Du L, Xue Y, Meng W, et al. (2013) Modified hypothermic circulatory arrest for emergent repair of acute aortic dissection type a: a single-center experience. J CardiothoracSurg8:125.
  6. Apostolakis E, Akinosoglou K (2007) What’s new in the biochemical diagnosis of acute aortic dissection: problems and perspectives. Med SciMonit 13: RA154-158.
  7. Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, et al. (2014) ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultThe Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35:2873-2926.
  8. Chirillo F, Marchiori MC, Andriolo L, Razzolini R, Mazzucco A, et al. (1990) Outcome of 290 patients with aortic dissection: a 12-year multicentre experience. Eur Heart J 11:311-319.
  9. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ (1990) Dissection of the aorta and dissecting aortic aneurysms: improving early and long-term surgical results. Circulation82: 24 -38.
  10. Rizzo RJ, Aranki AF, Aklog L, Couper GS, Adams DH, et al. (1994) Rapid noninvasive diagnosis and surgical repair of acute ascending aortic dissection. J Thor CardiovascSurg108:567-575.
  11. Doroghazi RM, Slater EE, DeSanctis RW, Buckley MJ, Austen WG, et al. (1984) Long-term survival of patients with treated aortic dissection. J Am CollCardiol3:1026-1034. 
  12. Glower DD, Fann JI, Speier RH, Morrison L, White WD, et al. Comparison of medical and surgical therapy for uncomplicated descending aortic dissection. Circulation82: 39-46.
  13. Haverich A, Miller DC, Scott WC, Mitchell RS, Oyer PE, et al. (1985) Acute and chronic aortic dissections-determinants of long-term outcome for operative survivors. Circulation72:22-34.
  14. Rizzoli G, Mazzucco A, Fracasso A, Giambuzzi M, Rubino M, et al. (1990) Early and late survival of repaired type A aortic dissection. EurCardiothoracSurg4:575-583. 
  15. Li M, Luo N, Bai Z (2012) A canine model of multiple organ dysfunction following acute type A aortic dissection.Surg Today 42:876.
  16. Emura I, Usuda H (2010) Histopathological and cytological examination of auotopsy cases with multiple organ dysfunction syndromes. PatholInt 60: 443.
  17. Cuschieri J, Bulger E, Schaeffer V (2010) Early elevation in random plasma IL-6 after severe injure is associated with development of organ failure. Shock 34:346.
  18. Deiteh EA, Xu D, Kaise VL (2006) Role of gut in the development of injury and shock induced SIRS and MODS; the gut-lymph hypothesis, a review. Front Biosci 11:520.
  19. Miao S, Ying C, Xia GH (2012) Plasma fibrinogen and its clinical significance in sub-acute thyroiditis. Chinese journal of internal medicine 32: 800.
  20. Grootjans J, Lenaeris K, Derikx JP (2010) Human intestinal ischemia- reperfusion induced inflammation characterized: experiences from a new translational model. Am J Pathol 176:2283.
  21. Nomura F, Tamura K, Yohitatsu M (2004) Change in coagulation condition, cytokines, adhesion molecules after repair of type A aortic dissection. Eur J CardiothoracSurg26: 348.
  22. Xu L, Burke A (2013) Acute medial dissection of the ascending aorta: evolution of reactive histologic changes. Am J SurgPathol 37:1275-1282.
Citation: Firoj KM, Fa XE, Yu HB, Huang ZF (2016) Role of Plasma Cytokines and Endotoxin in Patients with Acute Aortic Dissection. Immunome Res 12: 121.

Copyright: © 2016 Firoj KM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top